FIELD: biology, medicine. SUBSTANCE: hemosorption process is carried out at background of constant administration of antioxidant preparations in blood. The best result is obtained if an enzyme superoxide dismutase is used at the dose 50-500 mcg/kg. The aim of the invention is the development of curative tactics at hemosorption carrying out to correct complications caused by the presence of oxygen radicals as a result of blood leukocytes activation and can be used for carrying out of extracorporal hemocorrection. EFFECT: enhanced effectiveness of the method. 2 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF INDIVIDUAL EVALUATION OF SENSITIVITY TO HEMOCONTACT PREPARATIONS FOR HEMOSORPTION PROCEDURES IN PATIENTS | 1997 |
|
RU2122734C1 |
METHOD FOR IMPROVING TISSUE CIRCULATION BY ACTIVATED HUMORAL AND CELLULAR BLOOD ELEMENTS | 2001 |
|
RU2203098C1 |
METHOD FOR TREATING BURN WOUNDS | 2002 |
|
RU2210391C1 |
IMMUNOSORBENT FOR REMOVAL OF IMMUNE COMPLEX FORMED BY EQUINE IMMUNOGLOBULINS AFTER ADMINISTRATION OF ANTIDIPHTHERIA SERUM AND METHOD OF HEMOSORPTION CARRYING OUT IN DIPHTHERIA TREATMENT | 1998 |
|
RU2161504C2 |
METHOD OF ASSESSING THE ACTIVATION CAPABILITIES OF BLOOD-BORNUS PREPARATIONS (INCLUDING SORBENTS) BASED ON THE RATE OF BLOOD CELL ADHESION | 2018 |
|
RU2701722C1 |
METHOD FOR TREATMENT OF PATIENTS WITH CRITICAL LOWER LIMB ISCHEMIA | 2002 |
|
RU2233178C2 |
METHOD OF TISSUAL BLOOD FLOW CONTROL BY INDUCTION AND SYNTHESIS OF ENDOGENOUS VASOTROPIC SUBSTANCES OF EICOSANOIDS GROUP | 2009 |
|
RU2414247C2 |
USE OF SORBENT GRANULES FROM SUPER-CROSS-LINKED POLYSTYRENE "STIROSORB 516" AS A CONTACT HEMOACTIVATOR OF BLOOD CELL ELEMENTS | 2019 |
|
RU2712630C1 |
METHOD FOR TREATING PATIENTS FOR INFLAMMATORY AND PYONECROTIC FINGER AND HAND DISEASES | 2004 |
|
RU2282466C2 |
USE OF SILICA SORBENT "SILOCHROM S-120" GRANULES AS A BLOOD CELL ELEMENTS CONTACT HEMOACTIVATOR | 2019 |
|
RU2712626C1 |
Authors
Dates
1999-09-20—Published
1997-02-14—Filed